Comparative effectiveness of group v. individual trauma-focused treatment for posttraumatic stress disorder in veterans
Group cognitive processing therapy (CPT) was associated with a slightly smaller reduction of PTSD symptom severity than individual CPT or prolonged exposure (PE) in veterans at the end of residential treatment. There were no differences at 4-month follow-up.Source: Psychological Medicine
Association of Distress Due to Systemic Racism and Racial Disparities With Psychopathology and Suicidal Ideation Among US Veterans During the COVID-19 Pandemic
A team of Yale Psychiatry researchers analyzed data from a national sample of US veterans to examine the prevalence of perceived systemic racism and racial disparities in COVID-19–related health outcomes and the association of racism-related distress with internalizing and externalizing psychopathology and suicidal ideation during the pandemic.Source: The Journal of Clinical Psychiatry
Yale Scientists Identify Genetic Risk Factors for Opioid Use and Related Substance Use Disorders
A new human genomics study led by Yale scientists has identified genetic risk factors for opioid use disorder (OUD) and related substance use disorders according to a new large-scale genome-wide association study – increasing the number of risk genes known from 1 to 19.
Yale Study: Opioid Tapering Support Using a Web-based App
Sara N. Edmond, PhD, assistant professor of psychiatry, is first author of a paper in Contemporary Clinical Trials that describes the development and protocols of a web-based program designed to support patients willing to consider an opioid taper.Source: Contemporary Clinical Trials
Development and Validation of the Psychiatric Inpatient Experience (PIX) Survey: A Novel Measure of Patient Experience Quality Improvement
David Klemanski, PsyD, MPH, assistant professor of psychiatry, recently published a paper about a new survey he created alongside colleagues Todd Barnes and Cynthia Bautista to measure patient experience for inpatient psychiatry. The measure itself is part of a larger project of patient experience measures within Psychiatry and Behavioral Health.Source: Journal of Patient Experience
Bold Receives Grant to Study Impact of Menthol Flavor Ban in Cigarettes and E-cigarettes
Krysten Bold, PhD, assistant professor of psychiatry, has received an R01 grant from the National Institute on Drug Abuse (NIDA) to study the impact of a menthol flavor ban in cigarettes and e-cigarettes to inform tobacco policy.
Le Zhang, PhD Wins Avenir Award for Research on Substance Use Disorders and HIV/AIDS
Assistant Professor Le Zhang, PhD was recently awarded a DP2 grant from the National Institutes of Health (NIH), entitled “Immune Network Dysregulation of the Central Nervous System with HIV Persistence and Opioid Abuse.” The grant, which amounts to more than $2.5 million, began on May 15, 2022 and lasts for four years.
Sex Differences in the Acute Effects of Intravenous (IV) Delta‑9 Tetrahydrocannabinol (THC)
Anahita Bassir Nia, MD, assistant professor of psychiatry, and Mohini Ranganathan, MD, associate professor of psychiatry, are first and senior authors, respectively, of a paper in Psychopharmacology that investigated the sex differences in the acute effects of intravenous (IV) delta 9 tetrahydrocannabinol (THC), the main psychoactive compound of cannabis.Source: Psychopharmacology